On April 12, 2019 Vital Therapies, Inc. completed its previously announced stock-for-stock transaction with Immunic AG, Germany. In connection with the closing of the transaction, Vital Therapies has changed its name to Immunic, Inc. and the Company’s shares now trade on The Nasdaq Stock Market under the symbol “IMUX”.

Your browser will redirect you momentarily.
Alternatively, click here to immediately access the Immunic, Inc. website.